AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36451377 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical guideline-based management by ayurvedic practitioners
Number of subjects: 120
Study 36451377 — intervention group
Group type: COMPARATOR
Intervention: Usual ayurvedic management (without clinical guideline)
Number of subjects: 120
Study 34187116 — intervention group
Group type: EXPERIMENTAL
Intervention: Yogasana
Number of subjects: 40
Study 34187116 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 40
Study 35507530 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate Loading (IL)
Number of subjects: 14
Study 35507530 — intervention group
Group type: COMPARATOR
Intervention: Delayed Loading (DL)
Number of subjects: 14
Study 34187554 — intervention group
Group type: EXPERIMENTAL
Intervention: PDT under endoscopic guidance (FB)
Number of subjects: 0
Study 34187554 — intervention group
Group type: COMPARATOR
Intervention: Blind PDT
Number of subjects: 0
Study 33865361 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D (50,000 IU/week) plus Magnesium (6 mg/kg/day)
Number of subjects: 66
Study 33865361 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 33241650 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab (1200 mg, every 3 weeks)
Number of subjects: 986
Study 35550175 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Educational Tool to Enhance Recovery (BETTER) trial
Number of subjects: 0
Study 35550175 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote recruitment and consent process
Number of subjects: 0
Study 34549539 — intervention group
Group type: EXPERIMENTAL
Intervention: Rucaparib (600 mg twice daily)
Number of subjects: 254
Study 34549539 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 254
Study 32885374 — intervention group
Group type: EXPERIMENTAL
Intervention: BE-EHR module (six nudges)
Number of subjects: 680
Study 32885374 — intervention group
Group type: COMPARATOR
Intervention: Control group (baseline)
Number of subjects: 680
Study 32885374 — intervention group
Group type: COMPARATOR
Intervention: Control group (post intervention)
Number of subjects: 680
Study 36209731 — intervention group
Group type: EXPERIMENTAL
Intervention: Monterizine (combination of montelukast and levocetirizine)
Number of subjects: 2254
Study 34398113 — intervention group
Group type: EXPERIMENTAL
Intervention: Team size of 2 HCPs
Number of subjects: 109
Study 34398113 — intervention group
Group type: COMPARATOR
Intervention: Team size of 3 HCPs
Number of subjects: 109
Study 34398113 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision support tool (DST) use in the first scenario
Number of subjects: 109
Study 34398113 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision support tool (DST) use in the second scenario
Number of subjects: 109
Study 34398113 — intervention group
Group type: COMPARATOR
Intervention: Memory alone (control for DST)
Number of subjects: 109
Study 33261603 — intervention group
Group type: EXPERIMENTAL
Intervention: Hearing aids fitted immediately (Fitted group)
Number of subjects: 427
Study 33261603 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Not Fitted group)
Number of subjects: 427
Study 34241550 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalized model trained on both Taiwanese and U.S. data
Number of subjects: 536
Study 34241550 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalized model tested on U.S. data
Number of subjects: 536
Study 32104689 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma GDF-15 level
Number of subjects: 95
Study 32104689 — intervention group
Group type: EXPERIMENTAL
Intervention: MRC-score
Number of subjects: 95
Study 32104689 — intervention group
Group type: EXPERIMENTAL
Intervention: RFcsa
Number of subjects: 95
Study 35641047 — intervention group
Group type: EXPERIMENTAL
Intervention: DPPFit intervention (mobile health adaptation of the National Diabetes Prevention Program delivered via text messaging and Fitbit technology)
Number of subjects: 33
Study 33762421 — intervention group
Group type: EXPERIMENTAL
Intervention: IV metoclopramide 20 mg + diphenhydramine 25 mg (M + D)
Number of subjects: 160
Study 33762421 — intervention group
Group type: COMPARATOR
Intervention: IV placebo
Number of subjects: 160
Study 33369462 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral mefenamic acid (500 mg) 30 minutes before procedure
Number of subjects: 60
Study 33369462 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical tablet) 30 minutes before operation
Number of subjects: 60
Study 35687793 — intervention group
Group type: EXPERIMENTAL
Intervention: OC‐01 VNS 0.03 mg
Number of subjects: 1096
Study 35687793 — intervention group
Group type: COMPARATOR
Intervention: CsA 0.05% ophthalmic emulsion
Number of subjects: 1096
Study 33628014 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 μg·kg‐1·h‐1 dexmedetomidine combined with butorphanol (3 μg·kg‐1·h‐1)
Number of subjects: 114
Study 33628014 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05 μg·kg‐1·h‐1 dexmedetomidine combined with butorphanol (3 μg·kg‐1·h‐1)
Number of subjects: 114
Study 33628014 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.08 μg·kg‐1·h‐1 dexmedetomidine combined with butorphanol (3 μg·kg‐1·h‐1)
Number of subjects: 114
Study 33628014 — intervention group
Group type: COMPARATOR
Intervention: 0.9% sodium chloride combined with butorphanol (3 μg·kg‐1·h‐1)
Number of subjects: 114
Study 32461117 — intervention group
Group type: EXPERIMENTAL
Intervention: PVI + LA roof line + LA anterior wall line
Number of subjects: 214
Study 32461117 — intervention group
Group type: COMPARATOR
Intervention: PVI + LA roof line
Number of subjects: 214
Study 34180839 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized, physician-level quality measures submitted by family physicians
Number of subjects: 256
Study 34180839 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 256
Study 35442393 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital health intervention with gamification (virtual teams, points, levels for daily step goal achievement)
Number of subjects: 127
Study 35442393 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving daily feedback on goal attainment
Number of subjects: 127
Study 34911126 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR reminders 'on' for primary immunization series during well-child visits
Number of subjects: 15343
Study 34911126 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR reminders 'on' for primary immunization series during acute care visits
Number of subjects: 15343
Study 34911126 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR reminders 'on' for up-to-date immunization overall
Number of subjects: 15343
Study 32986770 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine (IVL)
Number of subjects: 534
Study 32986770 — intervention group
Group type: COMPARATOR
Intervention: No intravenous lidocaine (Control)
Number of subjects: 534
Study 35384422 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine 100 mg twice daily for 10 days
Number of subjects: 52
Study 35384422 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 35384422 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 52
Study 34348011 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation techniques (diaphragmatic breathing, progressive muscular relaxation, autogenic training, guided imagery) for 8 weeks, with weekly sessions and daily practice (2 times/day) using a compact disk.
Number of subjects: 64
Study 34348011 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation techniques (treatment group).
Number of subjects: 64
Study 34348011 — intervention group
Group type: COMPARATOR
Intervention: Control group (no relaxation techniques).
Number of subjects: 64
Study 35619246 — intervention group
Group type: EXPERIMENTAL
Intervention: MT associated with active tDCS (a-tDCS)
Number of subjects: 28
Study 35619246 — intervention group
Group type: COMPARATOR
Intervention: MT associated with sham tDCS (s-tDCS)
Number of subjects: 28
Study 33326929 — intervention group
Group type: EXPERIMENTAL
Intervention: Musical stimulation (15 minutes once daily for 7 days using an MP3 player and headphones)
Number of subjects: 54
Study 33326929 — intervention group
Group type: COMPARATOR
Intervention: Control group (silent headphones for 15 minutes once daily for 7 days)
Number of subjects: 54
Study 32617889 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV testing
Number of subjects: 0
Study 32617889 — intervention group
Group type: EXPERIMENTAL
Intervention: Colposcopy
Number of subjects: 0
Study 32617889 — intervention group
Group type: EXPERIMENTAL
Intervention: Pap smear
Number of subjects: 0
Study 32617889 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall sample
Number of subjects: 0
Study 33043347 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment group (ornidazole + periodontal tissue regeneration)
Number of subjects: 100
Study 34955070 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial education and coaching program
Number of subjects: 12
Study 34955070 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocreating Knowledge Translation Framework
Number of subjects: 12
Study 34955070 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions at individual, relationship, and community levels
Number of subjects: 12
Study 32960748 — intervention group
Group type: EXPERIMENTAL
Intervention: New glucose-lowering drug
Number of subjects: 0
Study 32960748 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 35775502 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal HIV testing and treatment (UTT)
Number of subjects: 6259
Study 34742266 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio-recordings of breast reconstruction explanation of surgery
Number of subjects: 32
Study 34742266 — intervention group
Group type: COMPARATOR
Intervention: Standard information package
Number of subjects: 32
Study 33662923 — intervention group
Group type: EXPERIMENTAL
Intervention: Power training group (countermovement jump and bench press throw at 40% of the 1-repetition maximum [1RM])
Number of subjects: 20
Study 33662923 — intervention group
Group type: COMPARATOR
Intervention: Strength training group (back squat and bench press at 70% to 90% of 1RM)
Number of subjects: 20
Study 33662923 — intervention group
Group type: EXPERIMENTAL
Intervention: iLOAD® application
Number of subjects: 20
Study 35841716 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofatumumab
Number of subjects: 0
Study 35841716 — intervention group
Group type: COMPARATOR
Intervention: Ocrelizumab
Number of subjects: 0
Study 32102605 — intervention group
Group type: COMPARATOR
Intervention: Dynamic auditory cueing (music or audio books presented as moving dynamically from right to left)
Number of subjects: 0
Study 32102605 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic meaningful auditory cues combined with optokinetic stimulation in a computer-based training
Number of subjects: 0
Study 35248549 — intervention group
Group type: EXPERIMENTAL
Intervention: GB001 20 mg
Number of subjects: 480
Study 35248549 — intervention group
Group type: EXPERIMENTAL
Intervention: GB001 40 mg
Number of subjects: 480
Study 35248549 — intervention group
Group type: EXPERIMENTAL
Intervention: GB001 60 mg
Number of subjects: 480
Study 35248549 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 480
Study 33177130 — intervention group
Group type: EXPERIMENTAL
Intervention: Visualisation and pictorial representation of advanced structural vascular disease (abdominal aortic calcification)
Number of subjects: 200
Study 33177130 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured questionnaires and semistructured in-depth interviews
Number of subjects: 200
Study 35251529 — intervention group
Group type: EXPERIMENTAL
Intervention: PFA‐ABCDE
Number of subjects: 221
Study 32172441 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based therapy for depressive symptoms
Number of subjects: 137
Study 35281318 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 μg/mL dexmedetomidine combined with 0.075% ropivacaine
Number of subjects: 120
Study 35281318 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural dexmedetomidine (combined with 0.075% ropivacaine)
Number of subjects: 120
Study 35281318 — intervention group
Group type: COMPARATOR
Intervention: 0 μg/mL dexmedetomidine combined with 0.075% ropivacaine
Number of subjects: 120
Study 35281318 — intervention group
Group type: COMPARATOR
Intervention: 0.1 μg/mL dexmedetomidine combined with 0.075% ropivacaine
Number of subjects: 120
Study 35281318 — intervention group
Group type: COMPARATOR
Intervention: 0.2 μg/mL dexmedetomidine combined with 0.075% ropivacaine
Number of subjects: 120
Study 35281318 — intervention group
Group type: COMPARATOR
Intervention: 0.3 μg/mL dexmedetomidine combined with 0.075% ropivacaine
Number of subjects: 120
Study 35281318 — intervention group
Group type: COMPARATOR
Intervention: 0.4 μg/mL dexmedetomidine combined with 0.075% ropivacaine
Number of subjects: 120
Study 32624244 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluocinolone acetonide insert (FAi) 0.2 μg/day
Number of subjects: 129
Study 35212646 — intervention group
Group type: EXPERIMENTAL
Intervention: Surrounding needling combined with NBUVB phototherapy
Number of subjects: 28
Study 35212646 — intervention group
Group type: COMPARATOR
Intervention: NBUVB phototherapy only
Number of subjects: 28
Study 35212646 — intervention group
Group type: COMPARATOR
Intervention: Comparison of intervention vs control
Number of subjects: 28
Study 33973063 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroticism
Number of subjects: 0
Study 33973063 — intervention group
Group type: COMPARATOR
Intervention: MDD, SWB, and insomnia
Number of subjects: 0
Study 32620212 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab alone (arms 1A and 4A)
Number of subjects: 0
Study 32620212 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab for 4 injections followed by nivolumab alone (arms 1B and 4B)
Number of subjects: 0
Study 32620212 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab followed by nivolumab alone (arms 2B and 3B)
Number of subjects: 0
Study 32620212 — intervention group
Group type: EXPERIMENTAL
Intervention: Tyrosine kinase inhibitor (sunitinib or pazopanib at investigator's choice) (arms 2C and 3C)
Number of subjects: 0
Study 35162381 — intervention group
Group type: EXPERIMENTAL
Intervention: Leg fidgeting (1 min on/4 min off)
Number of subjects: 13
Study 35162381 — intervention group
Group type: COMPARATOR
Intervention: Control (no leg fidgeting)
Number of subjects: 13
Study 33123838 — intervention group
Group type: EXPERIMENTAL
Intervention: OPT‐A (integrated family‐based outpatient treatment)
Number of subjects: 134
Study 33123838 — intervention group
Group type: COMPARATOR
Intervention: Usual services
Number of subjects: 134
Study 33017651 — intervention group
Group type: EXPERIMENTAL
Intervention: Airways therapy for OSA
Number of subjects: 0
Study 33017651 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (not treated for OSA)
Number of subjects: 0
Study 35503131 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (3 mg/kg)
Number of subjects: 15
Study 35503131 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 32760148 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive telephone peer support
Number of subjects: 17
Study 32760148 — intervention group
Group type: EXPERIMENTAL
Intervention: Volunteers' experiences
Number of subjects: 17
Study 36385314 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (CAF) 6 mg kg−1
Number of subjects: 90
Study 33999764 — intervention group
Group type: EXPERIMENTAL
Intervention: FNP2
Number of subjects: 20
Study 33999764 — intervention group
Group type: COMPARATOR
Intervention: Tru-Cut needle
Number of subjects: 20
Study 32043326 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal thoracic impedance (ITI) monitoring
Number of subjects: 70
Study 32043326 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 70
Study 35271721 — intervention group
Group type: EXPERIMENTAL
Intervention: Relighting cigarettes
Number of subjects: 49
Study 35271721 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency of smoking (number of smoking episodes/day)
Number of subjects: 49
Study 35271721 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in CPD
Number of subjects: 49
Study 34448448 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 infection in primary school students
Number of subjects: 1119
Study 34448448 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 infection in secondary school students
Number of subjects: 1119
Study 34448448 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 infection in staff
Number of subjects: 1119
Study 34448448 — intervention group
Group type: EXPERIMENTAL
Intervention: IgG antibodies in primary school students
Number of subjects: 1119
Study 34448448 — intervention group
Group type: EXPERIMENTAL
Intervention: IgG antibodies in secondary school students
Number of subjects: 1119
Study 34448448 — intervention group
Group type: EXPERIMENTAL
Intervention: IgG antibodies in household members
Number of subjects: 1119
Study 34448448 — intervention group
Group type: EXPERIMENTAL
Intervention: Household attack rate after 1 week
Number of subjects: 1119
Study 32554724 — intervention group
Group type: EXPERIMENTAL
Intervention: ASyMS-Can
Number of subjects: 114
Study 32554724 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 114
Study 35643334 — intervention group
Group type: EXPERIMENTAL
Intervention: rFOV-DWI
Number of subjects: 53
Study 35643334 — intervention group
Group type: COMPARATOR
Intervention: SMS-RESOLVE-DWI
Number of subjects: 53
Study 35643334 — intervention group
Group type: EXPERIMENTAL
Intervention: rFOV-DWI and SMS-RESOLVE-DWI
Number of subjects: 53
Study 34841235 — intervention group
Group type: EXPERIMENTAL
Intervention: MIL60
Number of subjects: 517
Study 34841235 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 517
Study 34897973 — intervention group
Group type: EXPERIMENTAL
Intervention: Students-mothers' education (2 sessions of 90 minutes)
Number of subjects: 261
Study 34897973 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 261
Study 33281043 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 T magnetic resonance imaging (MRI)
Number of subjects: 100
Study 33281043 — intervention group
Group type: COMPARATOR
Intervention: Control group (no MRI exposure)
Number of subjects: 100
Study 33281043 — intervention group
Group type: EXPERIMENTAL
Intervention: Different restorative materials
Number of subjects: 100
Study 32379655 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT)
Number of subjects: 96
Study 32379655 — intervention group
Group type: COMPARATOR
Intervention: Static Touch
Number of subjects: 96
Study 35780195 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventilatory settings (median tidal volume 7 mL/PBW, PEEP 7 cmH20, plateau pressure 20 cmH20, driving pressure 12 cmH20, mechanical power 16.2 J/min, ventilatory ratio 1.27, respiratory rate 17 breaths/min)
Number of subjects: 1848
Study 32281410 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal education (two 2-hr sessions twice a week for 4 weeks)
Number of subjects: 120
Study 32281410 — intervention group
Group type: COMPARATOR
Intervention: Control group (no antenatal education)
Number of subjects: 120
Study 32091467 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom-fitted compression garments (CF, n = 13)
Number of subjects: 45
Study 32091467 — intervention group
Group type: COMPARATOR
Intervention: Standard-sized compression garments (SSG, n = 16)
Number of subjects: 45
Study 32091467 — intervention group
Group type: COMPARATOR
Intervention: Sham ultrasound therapy (CON, n = 16)
Number of subjects: 45
Study 33177393 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% benvitimod cream
Number of subjects: 686
Study 33177393 — intervention group
Group type: COMPARATOR
Intervention: 0.005% calcipotriol ointment
Number of subjects: 686
Study 33177393 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 686
Study 33177393 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% benvitimod cream (retreatment)
Number of subjects: 686
Study 35366070 — intervention group
Group type: EXPERIMENTAL
Intervention: Left hand reaching with increased target distance
Number of subjects: 20
Study 35366070 — intervention group
Group type: EXPERIMENTAL
Intervention: Right hand reaching with visual feedback
Number of subjects: 20
Study 35366070 — intervention group
Group type: EXPERIMENTAL
Intervention: Right hand reaching without visual feedback
Number of subjects: 20
Study 35366070 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice with randomized trial schedule
Number of subjects: 20
Study 33302460 — intervention group
Group type: COMPARATOR
Intervention: Group Lifestyle Balance™ (GLB)
Number of subjects: 140
Study 33302460 — intervention group
Group type: EXPERIMENTAL
Intervention: lifestyle genomics (LGx)-based lifestyle intervention (GLB+LGx)
Number of subjects: 140
Study 33605036 — intervention group
Group type: EXPERIMENTAL
Intervention: COMBO stent
Number of subjects: 440
Study 33605036 — intervention group
Group type: COMPARATOR
Intervention: Nano polymer-free sirolimus-eluting stent
Number of subjects: 440
Study 32607688 — intervention group
Group type: EXPERIMENTAL
Intervention: DOAC (apixaban, rivaroxaban, dabigatran)
Number of subjects: 197
Study 32607688 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 197
Study 34218046 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilution of apomorphine
Number of subjects: 0
Study 34218046 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous hydrocortisone
Number of subjects: 0
Study 32893706 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchodilators
Number of subjects: 0
Study 32893706 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisone
Number of subjects: 0
Study 32893706 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic modalities for ACS
Number of subjects: 0
Study 36360666 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional triamcinolone acetonide injection, periodontal scaling, and oral hygiene instruction (experimental group)
Number of subjects: 48
Study 36360666 — intervention group
Group type: COMPARATOR
Intervention: Intralesional triamcinolone acetonide injection (control group)
Number of subjects: 48
Study 36088628 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab (DMAb) short-term (≤3 years; n=262)
Number of subjects: 752